Deep vein thrombosis as the first presentation of diabetic ketoacidosis

Highlights

References

• 1.
  Samama M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients. the sirius study. Arch Intern Med 2000; 160: 3415-3420.
• 2.
  Russell MW, Taylor DC, Cummins G, Huse DM. Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients. Am J Manag Care 2002; 8: S3-9.
• 3.
  Chung WS, Lin CL, Kao CH. Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study. Thromb Haemost 2015; 114: 812-818.
• 4.
  Burzynski J. DKA and thrombosis. CMAJ 2005; 173: 132-133.
• 5.
  Deep venous thrombosis (DVT). http://emedicine.medscape.com/article/1911303-overview#a6. Last updated Jul 06, 2017.
• 6.
  Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 2005; 48: 1017-1021.
• 7.
  Zhang Y, Shi Y, Ye R, Shao N, Pan F, Lin Y, et al. Diabetes mellitus-associated hyperglycemia is a risk factor for recurring deep vein thrombosis and post-thrombotic syndrome-a cohort study. Int J Clin Exp Med 2016; 9: 17739-17749.
• 8.
  Aso Y, Matsumoto S, Fujiwara Y, Tayama K, Inukai T, Takemura Y. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1. Metabolism 2002; 51: 471-476.
• 9.
  Murakami H, Okazaki M, Amagasa H, Oguchi K. Increase in hepatic mRNA expres-sion of coagulant factors in type 2 diabetic model mice. Thromb Res 2003; 111: 81-87.
• 10.
  Heit JA, Leibson CL, Ashrani AA, Petterson TM, Bailey KR, Melton LJ. Is diabetes mellitus an independent risk factor for venous thromboembolism? a population-based case-control study. Arterioscler Thromb Vasc Biol 2009; 29: 1399-1495.
• 11.
  Ho J, Pacaud D, Hill MD, Ross C, Hamiwka L, Mah JK. Diabetic ketoacidosis and pediatric stroke. CMAJ 2005; 172: 327-328.
• 12.
  Osinbowale O, Al Malki M, Schade A, Bartholomew JR. An algorithm for managing warfarin resistance. Cleve Clin J Med 2009; 76: 724-730.
• 13.
  Sandards of medical care in diabetes 2017. care.diabetesjournals.org/content/diacare/suppl/2016/12/15/40.../DC_40_S1_final.pdf.
• 14.
  Tomisti L, Del Re M, Bartalena L, Tanda M, Pucci A, Pambianco F, et al. Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature. Endocr Pract 2013; 19: 1043-1049##.